Breaking News
December 14, 2017 - These annual checkups help seniors not only survive but thrive
December 14, 2017 - Study reveals impact of diabetes during pregnancy on baby’s heart
December 14, 2017 - Huntington’s disease drug clears initial hurdles
December 14, 2017 - TPU researchers create 3D-printed models of children’s hearts
December 14, 2017 - Brain responses of children with inherited dyslexia risk predict their future reading speed
December 14, 2017 - Study: New Furosemide Formulation Simplifies Administration for HF
December 14, 2017 - Discrimination harms your health—and your partner’s
December 14, 2017 - Having older brothers may increase the likelihood of being gay
December 14, 2017 - New scientific yardstick released to help early detection of Alzheimer’s disease
December 14, 2017 - New finding demonstrates what happens at cellular level during onset of type2 diabetes
December 14, 2017 - Study identifies potassium as key to circadian rhythms in red blood cells
December 14, 2017 - NIH expected to award up to $70 million to launch Alzheimer’s Clinical Trials Consortium
December 14, 2017 - Pitting pathogens against each other could prevent drug resistance emerging
December 14, 2017 - Study provides new insights into development of Sonic Hedgehog medulloblastoma
December 14, 2017 - Dr. Reddy’s Announces Approval of Impoyz (clobetasol propionate) Cream for Plaque Psoriasis
December 14, 2017 - Gene Screens Can Alter Perception, Behavior
December 14, 2017 - Can Scrotal Vein Condition Hike Heart Risks?: MedlinePlus Health News
December 14, 2017 - Molecules in spit may be able to diagnose and predict length of concussions
December 14, 2017 - Children’s Colorado and RxRevu partner to help prescribers better meet needs of pediatric patients
December 14, 2017 - Researchers discover new way to attack drug-resistant prostate cancer cells
December 14, 2017 - Scientists develop new, high resolution method for identifying microbial species and strains
December 14, 2017 - Declining trend of salmonellosis cases has leveled off in the EU
December 14, 2017 - Death receptors in the blood can help measure risk of cardiovascular diseases, type 2 diabetes
December 14, 2017 - How to Perk Up the Holidays for Hospital Patients
December 14, 2017 - Prolonged Sedation May be Bad for Baby’s Brain
December 14, 2017 - The pediatric submersion score predicts children at low risk for injury following submersions
December 14, 2017 - Video game helps doctors to quickly recognize trauma patients who need high levels of care
December 14, 2017 - Younger persons newly-diagnosed with type 2 diabetes have poorer health than older patients
December 14, 2017 - Clinician re-examines evidence on re-use of catheters and UTIs in people with spinal cord injuries
December 14, 2017 - UK and Russian researchers join forces against AMR
December 14, 2017 - Results of Bariatric Surgery Hold Up Over Time
December 14, 2017 - High-intensity exercise delays Parkinson’s progression
December 14, 2017 - Protein structure could pave way for effective drugs to treat cystic fibrosis
December 14, 2017 - Minority people less likely to see dermatologist for psoriasis treatment
December 14, 2017 - Study indicates decline in use of chemotherapy for early stage breast cancer patients
December 14, 2017 - Chagas disease presents real public health problem to Canadians
December 14, 2017 - Experts call for rigorous clinical trials in use of experimental fetal therapy
December 14, 2017 - Lactic acid bacteria can offer protection against subtypes of influenza A virus
December 14, 2017 - Tapeworm drug could provide new hope for patients with Parkinson’s disease
December 14, 2017 - Parkinson’s progression delayed through high-intensity exercise, study says
December 14, 2017 - Researchers discover potential regulator essential for killer T cells to reside in tumors
December 14, 2017 - Tailor-made protein combats several kinds of pathogenic bacteria
December 14, 2017 - Hidden genes hold blueprints for designing new anti-cancer drugs
December 14, 2017 - Male virgins still at risk for acquiring HPV, study finds
December 14, 2017 - Study reveals novel molecular targets to improve chemotherapy’s efficiency against leukemia
December 14, 2017 - Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic Breast Cancer
December 14, 2017 - AHA: Hospital QI Initiative Fails to Budge Outcomes in India
December 14, 2017 - Scientists observe tremors associated with Parkinson’s disease in fruit flies
December 14, 2017 - Newly discovered molecular chaperones may soon be part of therapies for Huntington’s disease
December 14, 2017 - Performing surgery on virtual patient could provide valuable insight into consequences
December 13, 2017 - New insights into mosquito sex protein could provide strategies to control diseases
December 13, 2017 - Lilly’s Taltz (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis
December 13, 2017 - Step Into Sunshine | Medpage Today
December 13, 2017 - Poor Prognosis for Diabetic Foot Sores: MedlinePlus Health News
December 13, 2017 - Exercise alone does not lead to weight loss in women—in the medium term
December 13, 2017 - Researchers use new approach to identify casual mechanisms in depression
December 13, 2017 - Genetic Analysis and Bio-Rad enter into supply and distribution agreement for GA-map clinical test
December 13, 2017 - Study finds barriers to stem cell transplant use among multiple myeloma patients from minority groups
December 13, 2017 - Scientists discover how axons in developing visual system stabilize their connections
December 13, 2017 - Novel compound inhibits mycomembrane biosynthesis and kills tuberculosis bacteria
December 13, 2017 - FDA Launches New Tool for Sharing Information That Allows Doctors to Better Manage Antibiotic Use
December 13, 2017 - Evolocumab Wins FDA Approval for Stand-Alone CVD Prevention
December 13, 2017 - Powerful Clot-Busting Drugs Not Useful After Leg Blockages: Study: MedlinePlus Health News
December 13, 2017 - The fight against obesity: To tax or not to tax?
December 13, 2017 - Isolation during holidays can impact health of seniors
December 13, 2017 - Specialized physiotherapy provides many benefits for patients with Parkinson’s disease
December 13, 2017 - Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia
December 13, 2017 - Researchers find link between brain structure and hallucination proneness, musical aptitude
December 13, 2017 - Radiation responsive molecules derived from horse chestnuts aid cancer imaging
December 13, 2017 - New Gene Therapy May Be Cure for ‘Bubble Boy’ Disease
December 13, 2017 - MorningBreak: Insurance Driving Drug Prices? Crunch Time for ACA; The ‘Other’ Drug Problem
December 13, 2017 - Are Stents Really Useless After Chest Pain? Cardiologists Not Sure: MedlinePlus Health News
December 13, 2017 - Can you train yourself to develop ‘super senses’?
December 13, 2017 - Cellular self-digestion process plays role in development of autoimmune diseases
December 13, 2017 - E-cigarette use among youth leads to smoking as adults finds study
December 13, 2017 - New nanomaterial could enable new types of chemical processes in pharma, materials and chemical industries
December 13, 2017 - Another CGRP Drug Gains Ground in Migraine
December 13, 2017 - Trigger for most common form of vision loss discovered
December 13, 2017 - Study reveals link between estrogen and infertility
December 13, 2017 - Researchers suggest role for MKL1 protein in development of inflammatory bowel disease
New microscope optimized to perform studies using optogenetic techniques

New microscope optimized to perform studies using optogenetic techniques

image_pdfDownload PDFimage_print

A newly developed microscope is providing scientists with a greatly enhanced tool to study how neurological disorders such as epilepsy and Alzheimer’s disease affect neuron communication. The microscope is optimized to perform studies using optogenetic techniques, a relatively new technology that uses light to control and image neurons genetically modified with light-sensitive proteins.

“Our new microscope can be used to explore the effects of different genetic mutations on neuronal function,” said Adam Cohen from Harvard University, USA, and the leader of the research team that developed the microscope. “One day it could be used to test the effects of candidate drugs on neurons derived from people with nervous system disorders to try to identify medicines to treat diseases that do not have adequate treatments right now.”

The new microscope, called Firefly, can image a 6-millimeter-diameter area, more than one hundred times larger than the field of view of most microscopes used for optogenetics. Rather than studying the electrical activity of one neuron, the large imaging area makes it possible to trigger the electrical pulses neurons use to communicate and then watch those pulses travel from cell to cell throughout a large neural circuit containing hundreds of cells. In the brain, each neuron typically connects to one thousand other neurons, so viewing the larger network is important to understanding how neurological diseases affect neuronal communication.

In The Optical Society (OSA) journal Biomedical Optics Express, Cohen and his colleagues report how they assembled the new microscope for less than $100,000 using components that are almost all commercially available. The microscope not only images a large area, but also collects light extremely efficiently. This provides the high image quality and fast speed necessary to watch neuronal electrical pulses that each last only one-thousandth of a second.

Using light to see neurons fire

The new microscope is ideal for studying human neurons grown in the laboratory. In the past decade, scientists have developed human cell models for many nervous system disorders. These cells can be genetically modified to contain light-sensitive proteins that allow scientists to use light to make neurons fire or to control variables such as neurotransmitter levels or protein aggregation. Other light-sensitive fluorescent proteins turn the invisible electrical pulses coming from neurons into brief flashes of fluorescence that can be imaged and measured.

These techniques have made it possible for scientists to study the input and output of individual neurons, but commercially available microscopes aren’t optimized to fully utilize the potential of optogenetics approaches. To fill this technology gap, the researchers designed the Firefly microscope to stimulate neurons with a complex pattern containing a million points of light and then record the brief flashes of light fluorescence that correspond to electrical pulses fired by the neurons.

Each pixel of the light pattern can independently stimulate a light-sensitive protein. Because the pixels can be many distinct colors, different types of light-sensitive proteins can be triggered at once. The light pattern can be programmed to cover an entire neuron, stimulate certain areas of a neuron or be used to illuminate multiple cells at once.

“This optical system provides a million inputs and a million outputs, allowing us to see everything that’s going on in these neural cultures,” explained Cohen.

After stimulating the neurons, the microscope uses a camera imaging at a thousand frames a second to capture the fluorescence induced by the extremely short electrical pulses. “The optical system must be highly efficient to detect good signals within a millisecond,” said Cohen. “A great deal of engineering went into developing optics that can not only image a large area but do so with very high light collection efficiency.”

To efficiently collect light over a large area, the Firefly microscope uses an objective lens about the size of a soda can rather than the thumb-sized objective lens used by most microscopes. The researchers also used an optical setup that increases the amount of light stimulating the neurons to help ensure the neurons emit bright fluorescence when firing.

“The one custom element in the microscope is a small prism placed between the neurons and the objective lens,” explained Cohen. “This important component causes the light to travel along the same plane as the cells rather than entering the sample perpendicularly. This keeps the light from illuminating material above and below the cells, decreasing background fluorescence that would make it hard to see fluorescence actually coming from the neurons.”

Watching 85 neurons at once

The researchers demonstrated their new microscope by using it to optically stimulate and record the fluorescence from cultured human neurons. “The neurons were a big tangled mess of spaghetti,” said Cohen. “We showed that it was possible to resolve 85 individual neurons at the same time in a measurement that took about 30 seconds.”

After the initial stimulation and imaging, the researchers were able to find 79 of those 85 cells a second time. This capability is important for studies that require each cell to be imaged before and after exposure to a drug, for example.

In a second demonstration, the researchers used the microscope to map the electrical waves propagating through cultured heart cells. This showed that the microscope could be used to study abnormal heart rhythms, which occur when the electrical signals that coordinate heartbeats do not work properly.

“The system we developed is designed for looking at a relatively flat sample such as cultured cells,” said Cohen. “We are now developing a system to perform optogenetics approaches in intact tissue, which would allow us to look at how these neurons behave in their native context.”

The researchers have also started a biotech company called Q-State Biosciences that is using an improved version of the microscope to work with pharmaceutical companies on drug discovery.

Source:

http://www.osa.org/en-us/about_osa/newsroom/news_releases/2017/innovative_microscope_poised_to_propel_optogenetic/

Tagged with:

About author

Related Articles